OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Perils of prolonged ovarian suppression and hypoestrogenism in the treatment of breast cancer: Is the risk of treatment worse than the risk of recurrence?
Robert P. Kauffman, Christina B. Young, V. Daniel Castracane
Molecular and Cellular Endocrinology (2021) Vol. 525, pp. 111181-111181
Closed Access | Times Cited: 7
Robert P. Kauffman, Christina B. Young, V. Daniel Castracane
Molecular and Cellular Endocrinology (2021) Vol. 525, pp. 111181-111181
Closed Access | Times Cited: 7
Showing 7 citing articles:
Navigating skeletal wellness after breast cancer
Eleni Armeni
Maturitas (2025) Vol. 196, pp. 108250-108250
Closed Access
Eleni Armeni
Maturitas (2025) Vol. 196, pp. 108250-108250
Closed Access
Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy
Fatima Hassan, Anam Saleem, Sehar Saba Samuel, et al.
Medicine (2023) Vol. 102, Iss. 23, pp. e33978-e33978
Open Access | Times Cited: 9
Fatima Hassan, Anam Saleem, Sehar Saba Samuel, et al.
Medicine (2023) Vol. 102, Iss. 23, pp. e33978-e33978
Open Access | Times Cited: 9
Ovarian Suppression: Early Menopause, Late Effects
Chaya Goldberg, M Greenberg, Alexandra Noveihed, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 427-438
Closed Access | Times Cited: 2
Chaya Goldberg, M Greenberg, Alexandra Noveihed, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 5, pp. 427-438
Closed Access | Times Cited: 2
An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and Management
Nathalie LeVasseur, Mita Manna, Katarzyna J. Jerzak
Current Oncology (2024) Vol. 31, Iss. 8, pp. 4209-4224
Open Access | Times Cited: 2
Nathalie LeVasseur, Mita Manna, Katarzyna J. Jerzak
Current Oncology (2024) Vol. 31, Iss. 8, pp. 4209-4224
Open Access | Times Cited: 2
Comparative differential cytotoxicity of clinically used SERMs in human cancer lines of different origin and its predictive molecular docking studies of key target genes involved in cancer progression and treatment responses
S Lakshmi, A. Shanitha, Shiny Dv, et al.
Current Research in Pharmacology and Drug Discovery (2021) Vol. 3, pp. 100080-100080
Open Access | Times Cited: 6
S Lakshmi, A. Shanitha, Shiny Dv, et al.
Current Research in Pharmacology and Drug Discovery (2021) Vol. 3, pp. 100080-100080
Open Access | Times Cited: 6
Mechanistic and Clinical Chemoprevention
Jessica A. Moerland, A. Chowdhury, Christopher J. Occhiuto, et al.
Elsevier eBooks (2024)
Closed Access
Jessica A. Moerland, A. Chowdhury, Christopher J. Occhiuto, et al.
Elsevier eBooks (2024)
Closed Access
Prolonged endocrine therapy in the management of hormone receptor‐positive early‐stage breast cancer: What is the appropriate duration?
John P. Micha, Mark A. Rettenmaier, Randy D. Bohart, et al.
Journal of Obstetrics and Gynaecology Research (2023) Vol. 49, Iss. 4, pp. 1079-1082
Closed Access
John P. Micha, Mark A. Rettenmaier, Randy D. Bohart, et al.
Journal of Obstetrics and Gynaecology Research (2023) Vol. 49, Iss. 4, pp. 1079-1082
Closed Access
